PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsNHS England sets out personalised medicine strategy

BioNews

NHS England sets out personalised medicine strategy

Published 28 September 2015 posted in News and appears in BioNews 821

Author

Kirsty Oswald

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

NHS England's national medical director, Sir Bruce Keogh, has outlined how the organisation's approach to personalised medicine will develop over the coming years and expand beyond the work of the 100,000 Genomes Project...

NHS England's national medical director, Sir Bruce Keogh, has outlined how the organisation's approach to personalised medicine will develop over the coming years and expand beyond the work of the 100,000 Genomes Project (100KGP).

The strategy aims that, instead of treating patients on the basis of a set of symptoms, doctors will increasingly use emerging diagnostic technologies and genomics to detect the underlying causes of disease. By targeting interventions to the patients most likely to respond, the strategy is intended to lead to more effective and efficient treatment.

It also involves a greater role for preventive medicine, with the hope that diseases can be predicted and prevented, or else detected years earlier than they would be currently.

In a paper to the Board, Sir Bruce said that moving away from a 'one size fits all' approach to treatment would allow NHS England to become efficient and improve patient outcomes.

'Adopting a personalised medicine approach will allow the most appropriate intervention for the individual to be used, reducing costs and preventing adverse reactions in those who will not respond to certain treatments,' he writes.

'Given the current NHS drugs budget is over £12 billion, using diagnostics to guide treatment interventions is of fundamental importance to NHS England as a commissioning organisation.'

Proposals for implementation include developing the infrastructure of the NHS, including a national network of genomic testing laboratories emerging from the 100KGP, and greater harnessing of technology.

Professor Sue Hill, chief scientific officer, says that the integration of diagnostic, therapeutic and genetic data will also be essential.

'The NHS carries out more than a billion diagnostic tests every year, but we are only just learning the potential of all this information coming together to form an integrated picture over time — particularly when coupled with genomic sequence data,' she writes.

Professor Hill added: 'By taking a strategic approach to developing a more personalised approach to medicine, building on the learning coming through from NHS Genomic Medicine Centres, this country will be one of the most scientifically advanced in the world in use of genomics.'

However, Dr Stuart Hogarth, a senior research fellow from King's College London, said that while reorganisation of infrastructure to improve the quality of molecular diagnostic testing in the NHS 'seems very sensible' some of the plans may be ahead of the science.

'The very bold claims being made are not supported by many concrete examples,' Dr Hogarth told BioNews. 'We still have very few targeted therapies where the target population is defined using a companion diagnostic, and they are nearly all cancer drugs. Given that the front-line therapies in cancer are still surgery and radiotherapy, this is hardly a revolution in medicine.'

He also said that some of the assumptions made in the paper, such as that preventive therapy will be 'low cost', may not be a given.

'The same can be said for the promise of earlier detection — a laudable aim, but experience has taught us that screening needs to be rigorously evaluated to ensure that the benefits outweigh the harms,' he said.

NHS England will next be developing a five-year work programme, an investment plan and a review of potential cost savings and efficiency gains to be presented to the Board.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 July 2017 • 2 minutes read

Generation Genome - sequencing is future for NHS, says report

by Jen Willows

The Chief Medical Officer of England's annual report has recommended that personalised medicine approaches be adopted widely within the NHS.

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
28 July 2017 • 4 minutes read

What next for genomics? Providing answers, changing lives, transforming the NHS

by Dr Rachel Montgomery

A packed public event, produced by the Progress Educational Trust in partnership with Genomics England, saw the Chief Medical Officer for England launch her report 'Generation Genome'...

PET BioNews
Reviews
26 September 2016 • 2 minutes read

Radio Review: Personalised Medicine — Dose by Design

by Rhys Baker

Personalised Medicine. A promise of medical treatment tailored to the individual. A promise that has been decades in the delivery. But now, as such treatment appears to be within reach, will the dream be dashed by bureaucracy, inertia and funding crises?...

PET BioNews
News
19 September 2016 • 2 minutes read

Personalised medicine leads to better cancer outcomes

by Rachel Reeves

Genetic sequencing leading to targeted treatment significantly improves cancer patient outcomes in early-stage clinical trials, according to a study...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
5 April 2016 • 2 minutes read

Genetic test for child cancer patients

by Dr Jamie Heather

Hospitals around the UK are going to start examining the DNA of tumour cells from paediatric cancer patients in a pilot study starting later this year...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
24 August 2015 • 2 minutes read

Precision medicine approach effective in lung cancer

by Kirsty Oswald

Researchers have shown that a skin cancer drug can be used to treat advanced lung cancer in patients whose tumours harbour a particular mutation...

PET BioNews
News
10 April 2015 • 2 minutes read

Personalised cancer vaccines show promise

by Dr Nicoletta Charolidi

A new type of cancer vaccine that enriches the immune system with tailor-made anti-tumour antibodies has shown early signs of promise...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
13 March 2015 • 2 minutes read

100,000 Genomes Project leads to first diagnoses

by Dr Hannah Somers

Three British men have been diagnosed with rare diseases after having their complete genomes sequenced as part of the UK-based 100,000 Genomes Project...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 February 2015 • 2 minutes read

Obama puts $215 million price tag on precision medicine plan

by Dr Nikki Davis

The US President, Barack Obama, has revealed details of a multi-agency personalised medicine research plan...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 September 2014 • 2 minutes read

Personalised treatment on horizon for rare genetic disease patients

by Siobhan Chan

UK researchers have identified the most serious genetic mutations responsible for a rare condition that causes blindness, opening the door for personalised treatment and tailored gene therapies...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« STAP stem-cell findings were result of contamination

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856